Ulrik Dixen

2.9k total citations
49 papers, 852 citations indexed

About

Ulrik Dixen is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Ulrik Dixen has authored 49 papers receiving a total of 852 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Cardiology and Cardiovascular Medicine, 8 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Surgery. Recurrent topics in Ulrik Dixen's work include Atrial Fibrillation Management and Outcomes (25 papers), Cardiac Arrhythmias and Treatments (16 papers) and Cardiac electrophysiology and arrhythmias (15 papers). Ulrik Dixen is often cited by papers focused on Atrial Fibrillation Management and Outcomes (25 papers), Cardiac Arrhythmias and Treatments (16 papers) and Cardiac electrophysiology and arrhythmias (15 papers). Ulrik Dixen collaborates with scholars based in Denmark, United States and Finland. Ulrik Dixen's co-authors include Gorm Boje Jensen, Lars Køber, Jens Dahlgaard Hove, Christian Torp‐Pedersen, Michael Ottesen, Christian Jøns, Flemming Bendtsen, Søren Møller, Lasse Steen Ravn and Jan Parner and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and Diabetes.

In The Last Decade

Ulrik Dixen

44 papers receiving 829 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ulrik Dixen Denmark	16	727	130	100	90	72	49	852
Marina De Marco Italy	14	463 0.6×	126 1.0×	78 0.8×	49 0.5×	20 0.3×	23	566
L W Stevenson United States	7	939 1.3×	39 0.3×	212 2.1×	55 0.6×	16 0.2×	9	1.1k
Mai Takiguchi Japan	14	345 0.5×	35 0.3×	71 0.7×	60 0.7×	39 0.5×	18	490
Martı́n Rosas Mexico	12	373 0.5×	35 0.3×	101 1.0×	329 3.7×	13 0.2×	49	702
Nicola Tarantino Italy	18	815 1.1×	369 2.8×	216 2.2×	35 0.4×	21 0.3×	51	927
Kim P. Wagenaar Netherlands	6	534 0.7×	44 0.3×	72 0.7×	61 0.7×	5 0.1×	7	646
Gabriel Brooks United States	8	188 0.3×	44 0.3×	67 0.7×	100 1.1×	12 0.2×	15	433
G Maraglino Italy	10	413 0.6×	81 0.6×	114 1.1×	30 0.3×	17 0.2×	18	476
Katherine March United States	12	134 0.2×	25 0.2×	51 0.5×	76 0.8×	35 0.5×	22	344
Isac C. Thomas United States	15	318 0.4×	103 0.8×	88 0.9×	95 1.1×	3 0.0×	34	524

Countries citing papers authored by Ulrik Dixen

Since Specialization

Citations

This map shows the geographic impact of Ulrik Dixen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrik Dixen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrik Dixen more than expected).

Fields of papers citing papers by Ulrik Dixen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrik Dixen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrik Dixen. The network helps show where Ulrik Dixen may publish in the future.

Co-authorship network of co-authors of Ulrik Dixen

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrik Dixen. A scholar is included among the top collaborators of Ulrik Dixen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrik Dixen. Ulrik Dixen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hove, Jens Dahlgaard, et al.. (2025). Soluble urokinase plasminogen activator receptor and interleukin‐6 improves prediction of all‐cause mortality and major adverse cardiovascular events in Type 1 diabetes. Journal of Internal Medicine. 298(3). 188–199. 1 indexed citations

Jørgensen, Peter Godsk, Jens Dahlgaard Hove, Ulrik Dixen, et al.. (2023). Prognostic value of myocardial performance index in individuals with type 1 and type 2 diabetes: Thousand&1 and Thousand&2 studies. European Heart Journal - Cardiovascular Imaging. 24(11). 1555–1562. 2 indexed citations

Risom, Signe Stelling, et al.. (2023). Clinical outcomes of a short-term family-focused intervention for patients with atrial fibrillation–A randomised clinical trial. PLoS ONE. 18(3). e0282639–e0282639. 4 indexed citations

Elming, Marie Bayer, Sophia Hammer‐Hansen, Inga Voges, et al.. (2022). Myocardial fibrosis and ventricular ectopy in patients with non-ischemic systolic heart failure: results from the DANISH trial. The International Journal of Cardiovascular Imaging. 38(11). 2437–2445. 1 indexed citations

Feinberg, Joshua, Michael Hecht Olsen, Axel Brandes, et al.. (2021). Lenient rate control versus strict rate control for atrial fibrillation: a protocol for the Danish Atrial Fibrillation (DanAF) randomised clinical trial. BMJ Open. 11(3). e044744–e044744. 3 indexed citations

Thune, Jens Jakob, Steen Pehrson, Lars Køber, et al.. (2020). Atrial fibrillation is a marker of increased mortality risk in nonischemic heart failure—Results from the DANISH trial. American Heart Journal. 232. 61–70. 3 indexed citations

Martinussen, Torben, et al.. (2019). Recurrent event survival analysis predicts future risk of hospitalization in patients with paroxysmal and persistent atrial fibrillation. PLoS ONE. 14(6). e0217983–e0217983. 6 indexed citations

Lauridsen, Trine K., Arne Johannessen, Ulrik Dixen, et al.. (2017). Antiarrhythmic medication is superior to catheter ablation in suppressing supraventricular ectopic complexes in patients with atrial fibrillation. International Journal of Cardiology. 244. 186–191. 6 indexed citations

Holst, Line Marie, Ulrik Dixen, & Dorthe Lisbeth Jeppesen. (2014). Complete paroxysmal atrioventricular block in a 2-year-old girl. Cardiology in the Young. 25(7). 1407–1410.

10.

Munkholm-Larsen, Stine, Benjamin Wan, David H. Tian, et al.. (2013). A systematic review on the safety and efficacy of percutaneous edge-to-edge mitral valve repair with the MitraClip system for high surgical risk candidates. Heart. 100(6). 473–478. 39 indexed citations

11.

Kühl, Jørgen Tobias, Jesper J. Linde, Klaus F. Kofoed, et al.. (2013). Assessment of left atrial volume and function in patients with permanent atrial fibrillation: comparison of cardiac magnetic resonance imaging, 320-slice multi-detector computed tomography, and transthoracic echocardiography. European Heart Journal - Cardiovascular Imaging. 15(5). 532–540. 61 indexed citations

12.

Dixen, Ulrik, et al.. (2011). Increased Plasma Aldosterone during Atrial Fibrillation Declines following Cardioversion. Cardiology. 118(4). 239–244. 6 indexed citations

13.

Henningsen, K., Morten S. Olesen, Lasse Steen Ravn, et al.. (2010). Inflammatory single nucleotide polymorphisms and the risk of atrial fibrillation: a case control study. Inflammation Research. 60(3). 209–211. 6 indexed citations

14.

Jøns, Christian, Rikke Moerch Joergensen, Niels Thue Olsen, et al.. (2010). The incidence and prognostic significance of new-onset atrial fibrillation in patients with acute myocardial infarction and left ventricular systolic dysfunction: A CARISMA substudy. Heart Rhythm. 8(3). 342–348. 56 indexed citations

15.

Jøns, Christian, Pekka Raatikainen, Uffe Jakob Ortved Gang, et al.. (2010). Autonomic Dysfunction and New‐Onset Atrial Fibrillation in Patients With Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction: A CARISMA Substudy. Journal of Cardiovascular Electrophysiology. 21(9). 983–990. 44 indexed citations

16.

Dixen, Ulrik, et al.. (2008). Signal-averaged P wave duration and the long-term risk of permanent atrial fibrillation. Scandinavian Cardiovascular Journal. 42(1). 31–37. 14 indexed citations

17.

Dixen, Ulrik, et al.. (2004). Signal‐Averaged P Wave Duration and the Dimensions of the Atria. Annals of Noninvasive Electrocardiology. 9(4). 309–315. 10 indexed citations

18.

Ottesen, Michael, Ulrik Dixen, Christian Torp‐Pedersen, & Lars Køber. (2003). Prehospital behaviour of patients admitted with acute coronary syndrome or witnessed cardiac arrest. Scandinavian Cardiovascular Journal. 37(3). 141–148. 7 indexed citations

19.

Dixen, Ulrik, et al.. (2003). Prolonged signal-averaged P wave duration as a prognostic marker for morbidity and mortality in patients with congestive heart failure. Scandinavian Cardiovascular Journal. 37(4). 193–198. 12 indexed citations

20.

Dixen, Ulrik, Jan Parner, Verner Rasmussen, Steen Pehrson, & Gorm Boje Jensen. (2002). Atrial fibrillation recurrence: the roles of hypertension, duration of atrial fibrillation, and prolonged signal-averaged P wave duration. Journal of the American College of Cardiology. 39. 79–79.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact